- HOME
- ご挨拶
- 開催概要
- プログラム・日程表
- 演題登録／採択一覧
- 指定演題登録
- 参加登録
- 懇親会
- 参加者への案内
- 座長・演者への案内
- 協賛申込
- 会場案内
- 託児所のご案内
- Off-the-Job Training
- JCICウルトラクイズ
- リンク
ポスター【PDF】
運営事務局
株式会社プロコムインターナショナル
〒135-0063
東京都江東区有明三丁目6番地11
TFTビル東館9階
TEL：03-5520-8822
E-mail：jcic34@procom-i.jp
プログラム・日程表
プログラム
日程表
学術集会運営の都合上、プログラムに変更が生じる場合がございます。
予めご了承ください。
海外招請の先生 ご紹介
【Dr. Kyong-Jin Lee】
Dr. Kyong-Jin Lee is currently a Clinical Professor at Stanford University School of Medicine in the Department of Pediatrics, Division of Pediatric Cardiology. Her pediatric cardiology training was at the Hospital for Sick Children, Toronto, Columbia Presbyterian Medical Center, New York and Children’s Hospital of Pittsburgh. She was on faculty at the Hospital for Sick Children in Toronto, Canada. She then served as the Chief of Pediatric Cardiology and the Co-Director of the Children’s Hospital Foundation Heart Center at the Children’s Hospital of Richmond at VCU, USA. Dr. Lee’s main areas of clinical activities are in cardiac catheterization and echocardiography. Her research interests focus around integration of catheter-based and non-invasive imaging techniques and development of catheter-based interventional procedures.
【Dr. Juan Pablo Sandoval Jones】
【Dr. Juan Pablo Sandoval Jones】 Dr. Juan Pablo Sandoval Jones is a Professor of Pediatrics at the National University of Mexico, specializing in Pediatric Cardiology. He also serves as the Program Director for the Interventional Cardiology Fellowship in Congenital Heart Disease at the Ignacio Chavez National Institute of Cardiology in Mexico City. Additionally, he holds the position of Head of Pediatric Interventional Cardiology at the Pediatric Heart Center ABC-Kardias, located in the ABC Medical Center, Mexico City. He completed a fellowship in Pediatric Interventional Cardiology at the Hospital for Sick Children, University of Toronto. His clinical and research interests encompass various cardiac interventions, including perimembranous ventricular septal defect closure, right ventricular outflow tract stenting, coarctation of the aorta, and pulmonary arterial hypertension (PAH)-oriented cardiac interventions, as well as real-time combined Echo and CT-Fluoro Fusion Imaging. He is also a member of the National Research and Technology Council.
【Dr. Navaneetha Sasikumar】
Dr. Navaneetha Sasikumar is an Associate Professor in the Department of Pediatric Cardiology and oversees the Adult Congenital Heart Disease Service at the Amrita Institute of Medical Sciences in Kochi, India. Her qualifications include an MD in Pediatrics from Gandhi Medical College, Bhopal, a DM in Cardiology from Lokmanya Tilak Municipal Medical College and Hospital, Mumbai, and fellowships in Pediatric Cardiac Interventions and Adult Congenital and Structural Heart Disease Interventions from the University of Toronto, Canada. She successfully established a pediatric cardiac program in a public sector teaching hospital in India. Currently affiliated with Amrita University, her center conducts a substantial number of surgeries and interventions annually. She pioneered India's first comprehensive adult congenital heart disease clinic and have a strong research background, including the development of the "smiling heart" app for early congenital heart disease detection, which earned her a research award from "Women as One."
【Dr. Evan M. Zahn】
Evan Michael Zahn, MD, is a professor of Pediatrics and Director of the Guerin Family Congenital Heart Program in the Smidt Heart Institute at Cedars-Sinai Medical Center. He performed his pediatric cardiology and interventional fellowships at The Hospital For Sick Children in Toronto under the tutelage of Lee Benson and Bob Freedom. In 1995 he began the interventional catheterization program at Miami Children’s Hospital where he ultimately became Chief of Cardiology and was instrumental in developing the Congenital Heart Program at neighboring Arnold Palmer Children’s Hospital in Orlando. Dr. Zahn is a distinguished researcher in congenital interventional cardiology and has participated as both a site and national P.I. in numerous device trials, which have resulted in FDA approval of new devices for CHD patients in the United States. In 2007 he performed the world’s first transcatheter tricuspid valve implant and in 2018 the world’s first implant of the Altera pre-stent and Sapien 3. Other areas of focused exploration over his career have included: early post-operative intervention, development of hybrid procedures, the utility and feasibility of stents in small babies. As national PI, he recently spearheaded successful completion of the U.S. IDE trial of the Abbott Piccolo device for treatment of PDA in premature infants leading to the first-ever approval of a transcatheter device for infants as small as 700 grams. He has published extensively on these subjects and has performed and participated as both an organizer, speaker and operator in numerous live cases and educational symposia around the world. He serves on several editorial boards, advisory boards and councils including the SCAI CHD Council. In addition to travelling abroad for speaking, proctoring and teaching, Dr. Zahn is heavily involved in medical mission work providing interventional procedures for children in underprivileged countries.
